Johnson & Johnson/JNJ

$144.99

0.38%
-
1D1W1MYTD1YMAX

About Johnson & Johnson

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, and vision fields. These products are distributed to wholesalers, hospitals, and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

Ticker

JNJ

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Joaquin Duato

Employees

131,900

Headquarters

New brunswick, United States

JNJ Metrics

BasicAdvanced
$347B
Market cap
9.49
P/E ratio
$15.21
EPS
0.52
Beta
$4.76
Dividend rate
3.44%
Dividend yield
$347B
0.52492
$175.97
$143.13
7.5M
$4.76
1.17
0.936
35.821
48.032
66.9%
44.775
9.28%
24.23%
13.19%
9.493
4.057
4.963
49.59
2.61%
3.3%
3.44%
10.57%
69%
1.03%
-1.2%
5.7%

What the Analysts think about JNJ

Analyst Ratings

Majority rating from 24 analysts.
Buy

Price Targets

Average projection from 22 analysts.
19.13% upside
High $215.00
Low $155.00
$144.99
Current price
$172.72
Average price target

JNJ Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
15.22% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$21B
-0.06%
Net income
$3.3B
-19.61%
Profit margin
15.22%
-19.56%

JNJ Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.76%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.80
$2.66
$2.29
$2.71
-
Expected
$2.62
$2.52
$2.28
$2.64
$2.71
Surprise
7.02%
5.73%
0.4%
2.76%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Johnson & Johnson stock?

Johnson & Johnson (JNJ) has a market cap of $347B as of May 30, 2024.

What is the P/E ratio for Johnson & Johnson stock?

The price to earnings (P/E) ratio for Johnson & Johnson (JNJ) stock is 9.49 as of May 30, 2024.

Does Johnson & Johnson stock pay dividends?

Yes, the Johnson & Johnson (JNJ) stock pays dividends to shareholders. As of May 30, 2024, the dividend rate is $4.76 and the yield is 3.44%. Johnson & Johnson has a payout ratio of 66.9% on a trailing twelve-month basis.

When is the next Johnson & Johnson dividend payment date?

The next Johnson & Johnson (JNJ) dividend payment is scheduled for June 04, 2024.

What is the beta indicator for Johnson & Johnson?

Johnson & Johnson (JNJ) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Johnson & Johnson stock price target?

The target price for Johnson & Johnson (JNJ) stock is $172.72, which is 18.87% above the current price of $145.3. This is an average based on projections from 22 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Johnson & Johnson stock

Buy or sell Johnson & Johnson stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing